{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:21:31Z","timestamp":1792178491737,"version":"4.4.0"},"reference-count":92,"publisher":"Frontiers Media SA","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1111\/tri.12659","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T17:40:09Z","timestamp":1439919609000},"page":"515-526","source":"Crossref","is-referenced-by-count":17,"title":["Virus-specific T-cell therapy in solid organ transplantation"],"prefix":"10.3389","volume":"29","author":[{"given":"Andy","family":"Roemhild","sequence":"first","affiliation":[{"name":"Department of Nephrology and Internal Intensive Care; Charit\u00e9 Universit\u00e4tsmedizin Berlin; Berlin Germany"},{"name":"Berlin-Brandenburg Center for Regenerative Therapy (BCRT); Charit\u00e9 Universit\u00e4tsmedizin Berlin; Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Reinke","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Internal Intensive Care; Charit\u00e9 Universit\u00e4tsmedizin Berlin; Berlin Germany"},{"name":"Berlin-Brandenburg Center for Regenerative Therapy (BCRT); Charit\u00e9 Universit\u00e4tsmedizin Berlin; Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,9,9]]},"reference":[{"key":"10.1111\/tri.12659-BIB0001|tri12659-cit-0001","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.idc.2010.02.003","article-title":"Viral impact on long-term kidney graft function","volume":"24","author":"Helanter\u00e4","year":"2010","journal-title":"Infect Dis Clin North Am"},{"key":"10.1111\/tri.12659-BIB0002|tri12659-cit-0002","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1086\/324516","article-title":"Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir","volume":"184","author":"Razonable","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1111\/tri.12659-BIB0003|tri12659-cit-0003","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/MOT.0b013e3283324e1b","article-title":"Adenovirus infections in solid organ transplant recipients","volume":"14","author":"Hoffman","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/tri.12659-BIB0004|tri12659-cit-0004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.blre.2003.12.002","article-title":"Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease","volume":"18","author":"Burns","year":"2004","journal-title":"Blood Rev"},{"key":"10.1111\/tri.12659-BIB0005|tri12659-cit-0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.bmt.1705906","article-title":"Adoptive cellular immunotherapy for viral diseases","volume":"41","author":"Fujita","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/tri.12659-BIB0006|tri12659-cit-0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399401003842","article-title":"Epstein - Barr virus infection\u202f: basis of malignancy and potential for therapy","volume":"44","author":"Murray","year":"2001","journal-title":"Expert Rev Mol Med"},{"key":"10.1111\/tri.12659-BIB0007|tri12659-cit-0007","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1084\/jem.185.9.1605","article-title":"Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr Virus - induced cytotoxic T cell response","volume":"185","author":"Steven","year":"1997","journal-title":"J Exp Med"},{"key":"10.1111\/tri.12659-BIB0008|tri12659-cit-0008","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2217\/imt.10.43","article-title":"Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation","volume":"2","author":"Shaffer","year":"2010","journal-title":"Immunotherapy"},{"key":"10.1111\/tri.12659-BIB0009|tri12659-cit-0009","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11908-010-0145-9","article-title":"Posttransplant lymphoproliferative disease in liver transplant patients","volume":"13","author":"Hartmann","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"10.1111\/tri.12659-BIB0010|tri12659-cit-0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1034\/j.1399-3062.2001.003002070.x","article-title":"Identifying the patient at risk for post-transplant lymphoproliferative disorder","volume":"3","author":"Cockfield","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/tri.12659-BIB0011|tri12659-cit-0011","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1034\/j.1399-3046.2002.02043.x","article-title":"Epstein - Barr virus and post-transplant lymphoproliferative disease","volume":"6","author":"Holmes","year":"2002","journal-title":"Pediatr Transplant"},{"key":"10.1111\/tri.12659-BIB0012|tri12659-cit-0012","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/jinf.2001.0948","article-title":"Latency and reactivation of human cytomegalovirus","volume":"44","author":"Sissons","year":"2002","journal-title":"J Infect"},{"key":"10.1111\/tri.12659-BIB0013|tri12659-cit-0013","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1111\/tri.12659-BIB0014|tri12659-cit-0014","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/petr.12118","article-title":"Prevention of cytomegalovirus following solid organ transplantation: a literature review","volume":"17","author":"Kowalsky","year":"2013","journal-title":"Pediatr Transplant"},{"key":"10.1111\/tri.12659-BIB0015|tri12659-cit-0015","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/MOT.0b013e32834016b9","article-title":"T-cell therapy for cytomegalovirus infection","volume":"15","author":"Mui","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/tri.12659-BIB0016|tri12659-cit-0016","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1399-3046.2010.01330.x","article-title":"The efficacy and safety of valganciclovir vs. oral ganciclovir in the prevention of symptomatic CMV infection in children after solid organ transplantation","volume":"14","author":"Lapidus-Krol","year":"2010","journal-title":"Pediatr Transplant"},{"key":"10.1111\/tri.12659-BIB0017|tri12659-cit-0017","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.3748\/wjg.v20.i31.10658","article-title":"Cytomegalovirus infection in liver transplant recipients: updates on clinical management","volume":"20","author":"Marcelin","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1111\/tri.12659-BIB0018|tri12659-cit-0018","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/tri.12659-BIB0019|tri12659-cit-0019","first-page":"1","article-title":"Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients","volume":"2","author":"Owers","year":"2013","journal-title":"Cochrane Libr"},{"key":"10.1111\/tri.12659-BIB0020|tri12659-cit-0020","doi-asserted-by":"crossref","first-page":"820621","DOI":"10.1100\/2012\/820621","article-title":"Viral infection in renal transplant recipients","volume":"2012","author":"Cukuranovic","year":"2012","journal-title":"ScientificWorldJournal"},{"issue":"Suppl. 4","key":"10.1111\/tri.12659-BIB0021|tri12659-cit-0021","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1111\/j.1600-6143.2009.02897.x","article-title":"Cytomegalovirus in solid organ transplant recipients","volume":"9","author":"Humar","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12659-BIB0022|tri12659-cit-0022","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/rmv.386","article-title":"The impact of adenovirus infection on the immunocompromised host","volume":"13","author":"Kojaoghlanian","year":"2003","journal-title":"Rev Med Virol"},{"key":"10.1111\/tri.12659-BIB0023|tri12659-cit-0023","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/infdis\/165.1.170","article-title":"Adenovirus infection in pediatric liver transplant recipients","volume":"165","author":"Michaels","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1111\/tri.12659-BIB0024|tri12659-cit-0024","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CMR.00052-07","article-title":"Adenoviruses in immunocompromised hosts","volume":"21","author":"Echavarr\u00eda","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/tri.12659-BIB0025|tri12659-cit-0025","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM200105173442002","article-title":"Association of viral genome with graft loss in children after cardiac transplantation","volume":"344","author":"Shirali","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12659-BIB0026|tri12659-cit-0026","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.4049\/jimmunol.177.12.8851","article-title":"Adenovirus-specific CD4+ T cell clones recognizing endogenous antigen inhibit viral replication in\u00a0vitro through cognate interaction","volume":"177","author":"Heemskerk","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/tri.12659-BIB0027|tri12659-cit-0027","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1182\/blood-2004-02-0646","article-title":"Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8 + T cells","volume":"104","author":"Leen","year":"2004","journal-title":"Blood"},{"key":"10.1111\/tri.12659-BIB0028|tri12659-cit-0028","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12185-011-0782-2","article-title":"Immunotherapy for EBV-associated malignancies","volume":"93","author":"Merlo","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1111\/tri.12659-BIB0029|tri12659-cit-0029","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/TP.0b013e3181761659","article-title":"Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder","volume":"86","author":"Swinnen","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/tri.12659-BIB0030|tri12659-cit-0030","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/j.1600-6143.2005.01002.x","article-title":"Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients","volume":"5","author":"Lee","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12659-BIB0031|tri12659-cit-0031","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/01.inf.0000233542.48267.fd","article-title":"Adenoviral infections in pediatric transplant recipients","volume":"25","author":"Herna","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/tri.12659-BIB0032|tri12659-cit-0032","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1517\/14712598.2012.693471","article-title":"Therapeutic strategies for the prevention and treatment of cytomegalovirus infection","volume":"12","author":"Sellar","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1111\/tri.12659-BIB0033|tri12659-cit-0033","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/S0140-6736(00)02350-3","article-title":"Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation","volume":"355","author":"Emery","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/tri.12659-BIB0034|tri12659-cit-0034","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/lt.23460","article-title":"Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients","volume":"18","author":"Bodro","year":"2012","journal-title":"Liver Transplant"},{"key":"10.1111\/tri.12659-BIB0035|tri12659-cit-0035","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/JCM.06406-11","article-title":"Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection","volume":"50","author":"Abate","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1111\/tri.12659-BIB0036|tri12659-cit-0036","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.bmt.1702226","article-title":"Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection","volume":"25","author":"Einsele","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/tri.12659-BIB0037|tri12659-cit-0037","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3324\/haematol.10595","article-title":"CHOP-21 for the treatment of post-transplant lymphoproliferative disorders following solid organ","volume":"92","author":"Choquet","year":"2007","journal-title":"Hematol J"},{"key":"10.1111\/tri.12659-BIB0038|tri12659-cit-0038","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/2040620711412417","article-title":"Therapeutic options in post-transplant lymphoproliferative disorders","volume":"2","author":"Zimmermann","year":"2011","journal-title":"Ther Adv Hematol"},{"key":"10.1111\/tri.12659-BIB0039|tri12659-cit-0039","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1038\/sj.onc.1206939","article-title":"Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance","volume":"22","author":"Smith","year":"2003","journal-title":"Oncogene"},{"key":"10.1111\/tri.12659-BIB0040|tri12659-cit-0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/scd.1.1995.4.73","article-title":"Genetically modified Epstein-Barr virus- high risk of EBV-associated lymphoproliferative disease Epstein-Barr","volume":"79","author":"Smith","year":"1995","journal-title":"J Hematother"},{"key":"10.1111\/tri.12659-BIB0041|tri12659-cit-0041","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1182\/blood.V98.3.505","article-title":"Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers","volume":"98","author":"Szmania","year":"2001","journal-title":"Blood"},{"key":"10.1111\/tri.12659-BIB0042|tri12659-cit-0042","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.4049\/jimmunol.169.4.2164","article-title":"Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cells","volume":"169","author":"Kondo","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/tri.12659-BIB0043|tri12659-cit-0043","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1182\/blood.V96.1.109","article-title":"Rapid selection of antigen-specific T lymphocytes by retroviral transduction","volume":"96","author":"Koehne","year":"2000","journal-title":"Blood"},{"key":"10.1111\/tri.12659-BIB0044|tri12659-cit-0044","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1111\/j.1537-2995.2007.01439.x","article-title":"Expansion of human cytomegalovirus-specific T lymphocytes from unfractionated peripheral blood mononuclear cells with artificial antigen-presenting cells","volume":"47","author":"Paine","year":"2007","journal-title":"Transfusion"},{"key":"10.1111\/tri.12659-BIB0045|tri12659-cit-0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2141.2001.02681.x","article-title":"Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells","volume":"113","author":"Kleihauer","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/tri.12659-BIB0046|tri12659-cit-0046","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1182\/blood.V97.4.994","article-title":"Induction of cytomegalovirus (CMV)- specific T-cell responses using dendritic cells pulsed with CMV antigen\u202f: a novel culture system free of live CMV virions","volume":"97","author":"Peggs","year":"2001","journal-title":"Blood"},{"key":"10.1111\/tri.12659-BIB0047|tri12659-cit-0047","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"10.1111\/tri.12659-BIB0048|tri12659-cit-0048","first-page":"410","article-title":"Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry","volume":"3","author":"Eiz-Vesper","year":"2012","journal-title":"Front Immunol"},{"key":"10.1111\/tri.12659-BIB0049|tri12659-cit-0049","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1046\/j.1365-2141.2001.03106.x","article-title":"Purification of cytomegalovirus-specific CD8 T cells from peripheral blood using HLA \u00b1 peptide tetramers","volume":"115","author":"Keenan","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/tri.12659-BIB0050|tri12659-cit-0050","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/eji.200526230","article-title":"New technology HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy","volume":"35","author":"Hammer","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1111\/tri.12659-BIB0051|tri12659-cit-0051","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm0898-975","article-title":"T-cell epitope mapping by flow cytometry","volume":"4","author":"Kern","year":"1998","journal-title":"Nat Med"},{"key":"10.1111\/tri.12659-BIB0052|tri12659-cit-0052","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/CJI.0b013e3181b88fda","article-title":"Generation of HCMV-specific T-cell lines from seropositive solid-organ-transplant recipients for adoptive T-cell therapy","volume":"32","author":"Brestrich","year":"2009","journal-title":"Immunother J"},{"key":"10.1111\/tri.12659-BIB0053|tri12659-cit-0053","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1600-6143.2009.02672.x","article-title":"Adoptive T-cell therapy of a lung transplanted patient with severe CMV disease and resistance to antiviral therapy","volume":"9","author":"Brestrich","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12659-BIB0054|tri12659-cit-0054","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/mt.2012.130","article-title":"Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections","volume":"20","author":"Gerdemann","year":"2012","journal-title":"Mol Ther"},{"key":"10.1111\/tri.12659-BIB0055|tri12659-cit-0055","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(02)09672-1","article-title":"Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells","volume":"360","author":"Haque","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/tri.12659-BIB0056|tri12659-cit-0056","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":"Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease\u202f: results of a phase 2 multicenter clinical trial","volume":"110","author":"Haque","year":"2007","journal-title":"Blood"},{"key":"10.1111\/tri.12659-BIB0057|tri12659-cit-0057","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri1526","article-title":"Cellular immunotherapy","volume":"5","author":"Moss","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/tri.12659-BIB0058|tri12659-cit-0058","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ni1105","article-title":"CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection","volume":"5","author":"Sun","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1111\/tri.12659-BIB0059|tri12659-cit-0059","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.uct.2008.01.001","article-title":"Adoptive cellular therapy with T cells specific for EBV-derived tumor antigens","volume":"3","author":"Craddock","year":"2009","journal-title":"Updat Cancer Ther"},{"key":"10.1111\/tri.12659-BIB0060|tri12659-cit-0060","first-page":"93","article-title":"HCMV-specific T-cell therapy\u202f: do not forget supply of help","volume":"36","author":"Hammoud","year":"2013","journal-title":"J\u00a0Immunother"},{"key":"10.1111\/tri.12659-BIB0061|tri12659-cit-0061","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.4049\/jimmunol.1103763","article-title":"Preferential expansion of human virus-specific multifunctional central memory T cells by partial targeting of the IL-2 receptor signaling pathway: the key role of CD4+ T cells","volume":"188","author":"Schmueck","year":"2012","journal-title":"J Immunol"},{"key":"10.1111\/tri.12659-BIB0062|tri12659-cit-0062","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.trim.2006.10.006","article-title":"Quantitative analysis of EBV-specific CD4\/CD8 T cell numbers, absolute CD4\/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD","volume":"17","author":"Sebelin-Wulf","year":"2007","journal-title":"Transpl Immunol"},{"key":"10.1111\/tri.12659-BIB0063|tri12659-cit-0063","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","article-title":"Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation","volume":"134","author":"Feuchtinger","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/tri.12659-BIB0064|tri12659-cit-0064","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri1842","article-title":"Adoptive immunotherapy for cancer: building on success","volume":"6","author":"Gattinoni","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/tri.12659-BIB0065|tri12659-cit-0065","doi-asserted-by":"crossref","first-page":"9571","DOI":"10.1073\/pnas.0503726102","article-title":"Central memory self tumor-reactive CD8 + T cells confer superior antitumor immunity compared with effector memory T cells","volume":"102","author":"Klebanoff","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/tri.12659-BIB0066|tri12659-cit-0066","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1172\/JCI32103","article-title":"Adoptive transfer of effector CD8 + T cells derived from central memory cells establishes persistent T cell memory in primates","volume":"118","author":"Berger","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1111\/tri.12659-BIB0067|tri12659-cit-0067","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"key":"10.1111\/tri.12659-BIB0068|tri12659-cit-0068","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.4049\/jimmunol.0804211","article-title":"Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells","volume":"182","author":"Grosso","year":"2009","journal-title":"J Immunol"},{"key":"10.1111\/tri.12659-BIB0069|tri12659-cit-0069","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1182\/blood.V93.5.1506","article-title":"Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome","volume":"93","author":"Tan","year":"1999","journal-title":"Blood"},{"key":"10.1111\/tri.12659-BIB0070|tri12659-cit-0070","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"10.1111\/tri.12659-BIB0071|tri12659-cit-0071","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/592170","article-title":"Progressive telomere shortening of Epstein-Barr virus-specific memory T cells during HIV infection: contributor to exhaustion?","volume":"198","author":"Van Baarle","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1111\/tri.12659-BIB0072|tri12659-cit-0072","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1600-6143.2011.03842.x","article-title":"Cytomegalovirus-specific regulatory and effector T cells share TCR clonality-possible relation to repetitive CMV infections","volume":"12","author":"Schwele","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12659-BIB0073|tri12659-cit-0073","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.4049\/jimmunol.160.12.6204","article-title":"Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients","volume":"160","author":"Haque","year":"1998","journal-title":"J Immunol"},{"key":"10.1111\/tri.12659-BIB0074|tri12659-cit-0074","doi-asserted-by":"crossref","first-page":"10391","DOI":"10.1073\/pnas.96.18.10391","article-title":"Activation and adoptive transfer of Epstein - Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease","volume":"96","author":"Khanna","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/tri.12659-BIB0075|tri12659-cit-0075","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1182\/blood.V99.7.2592","article-title":"Infusion of autologous Epstein-Barr virus (EBV)- specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication","volume":"99","author":"Comoli","year":"2002","journal-title":"Blood"},{"key":"10.1111\/tri.12659-BIB0076|tri12659-cit-0076","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1365-2141.2002.03683.x","article-title":"Safety of allogeneic Epstein - Barr virus (EBV) -specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma","volume":"118","author":"Sun","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/tri.12659-BIB0077|tri12659-cit-0077","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1600-6143.2007.01796.x","article-title":"Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disorders","volume":"7","author":"Gandhi","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12659-BIB0078|tri12659-cit-0078","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1097\/01.TP.0000058745.02123.6F","article-title":"Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy","volume":"75","author":"Sherritt","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/tri.12659-BIB0079|tri12659-cit-0079","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1600-6143.2005.00854.x","article-title":"Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-specific T cells","volume":"5","author":"Comoli","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12659-BIB0080|tri12659-cit-0080","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood-2006-05-021782","article-title":"Treatment of solid organ transplant recipients with autologous Epstein Barr virus - specific cytotoxic T lymphocytes (CTLs)","volume":"108","author":"Savoldo","year":"2006","journal-title":"Blood"},{"key":"10.1111\/tri.12659-BIB0081|tri12659-cit-0081","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/ajt.13023","article-title":"Case report adoptive T cell immunotherapy for treatment of ganciclovir-resistant cytomegalovirus disease in a renal transplant recipient","volume":"15","author":"Macesic","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12659-BIB0082|tri12659-cit-0082","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/oxfordjournals.jncimonographs.a024180","article-title":"Immunotherapy for Epstein-Barr virus-associated cancers","volume":"23","author":"Rooney","year":"1998","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1111\/tri.12659-BIB0083|tri12659-cit-0083","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","article-title":"Infusion of cytomegalovirus (CMV)- specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy","volume":"99","author":"Einsele","year":"2015","journal-title":"Blood"},{"key":"10.1111\/tri.12659-BIB0084|tri12659-cit-0084","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.exphem.2003.12.009","article-title":"Isolation and expansion of human adenovirus - specific CD4 + and CD8 + T cells according to IFN- \u03b3 secretion for adjuvant immunotherapy","volume":"32","author":"Feuchtinger","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1111\/tri.12659-BIB0085|tri12659-cit-0085","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.20040613","article-title":"Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers","volume":"202","author":"Cobbold","year":"2005","journal-title":"J Exp Med"},{"key":"10.1111\/tri.12659-BIB0086|tri12659-cit-0086","unstructured":"The Innovation Office at the Paul-Ehrlich-Institut ATMP Decision-Tree 2011"},{"key":"10.1111\/tri.12659-BIB0087|tri12659-cit-0087","unstructured":"The European Parliament and the Council of the European, Union 2007"},{"key":"10.1111\/tri.12659-BIB0088|tri12659-cit-0088","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/mt.2012.13","article-title":"Clinical development of advanced therapy medicinal products in Europe: evidence that regulators must be proactive","volume":"20","author":"Maciulaitis","year":"2012","journal-title":"Mol Ther"},{"key":"10.1111\/tri.12659-BIB0089|tri12659-cit-0089","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jcyt.2013.08.003","article-title":"Regulation of advanced therapy medicinal products in Europe and the role of academia","volume":"16","author":"Pearce","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1111\/tri.12659-BIB0090|tri12659-cit-0090","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jcyt.2012.09.006","article-title":"Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs","volume":"15","author":"Abou-El-Enein","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1111\/tri.12659-BIB0091|tri12659-cit-0091","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/mt.2013.151","article-title":"Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant","volume":"21","author":"Gerdemann","year":"2013","journal-title":"Mol Ther"},{"key":"10.1111\/tri.12659-BIB0092|tri12659-cit-0092","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci Transl Med"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.12659","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.12659\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T07:10:48Z","timestamp":1691910648000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.12659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,9]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.12659","archive":["Portico"],"relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9,9]]}}}